Table 2.
Additional clinical features of the IVH infants tested.
| Infant No. | Ultrasound Time before exama | Evidence of progression of GMH-IVH on repeated head US | Blood Glucose (mmol/L) | Blood Gas (mmHg) | Blood pH | Hemoglobin level (g/dl) | Ventilatory support and/or mechanical ventilationb | Treatments with possible interfering effect | seizures and/or AED treatments |
|---|---|---|---|---|---|---|---|---|---|
| pCO2 | |||||||||
| pO2 | |||||||||
| 1 | D-1: IVH3 | D + 8: IVH3 | 4.2 | 36.1 | 7.27 | 10.6 | IMV | celestene | – |
| D + 14: IVH3 | 123 | ||||||||
| 2 | D-0: IVH3 | D + 5: IVH4 | 4.7 | 48.3 | 7.16 | 7.7 | CPAP | celestene | – |
| 64 | |||||||||
| 3 | D-9: IVH3 | D + 6: Tetra ventricular hydrocephaly and bilateral IVH | 7.8 | 38.6 | 7.27 | 9 | IMV | celestene | – |
| 62.2 | |||||||||
| 4 | D-9: IVH3 | D + 0: asymmetry of lateral ventricle (L > R) D + 8: IVH 3 | 4.8 | 52.8 | 7.32 | 8 | IMV | celestene hypnovel, | – |
| 39.1 | sufentanyl | ||||||||
| 5 | D-3: IVH4 | D + 5: IVH4 | 2.6 | 66.8 | 7.28 | 13.2 | AA | celestene | – |
| 49.2 | |||||||||
| 6 | D-5: IVH4 | D + 3: IVH4 | 5.3 | 37 | 7.34 | 11.6 | IMV | celestene | – |
| 93.7 | sufentanyl | ||||||||
| 7 | D-17: IVH3 | D + 8: IVH4 | 4.6 | 33.3 | 7.28 | 12.4 | IMV | celestene | – |
| 128 | |||||||||
| 8 | D-2: IVH3 | D + 5: IVH3 | 4.9 | 54.2 | 7.28 | 12.4 | IMV | hypnovel, | – |
| 107 | sufentanyl |
a
“D” is fNIRS exam Day (e.g. D-1: one day prior exam).
b
CPAP: Continuous positive airway pressure, IMV: Intermittent Mandatory Ventilation, AA: Ambient Air.